Archives: Agenda

• The evolution of automotive financial services over the past four decades—and the forces shaping the next decade.
• Why customer expectations, not technology alone, are driving the industry’s transformation.
• From ownership to access: the emergence of flexible, digital and customer-centric mobility solutions.
• How AI and digital innovation are fundamentally reshaping the customer journey and the automotive retail experience.
• The changing roles of OEMs, dealers and finance companies in a rapidly evolving mobility ecosystem.
• Building trusted customer relationships in an increasingly digital world.
• The human side of transformation: Why the future belongs to companies that combine technology with trust, innovation with simplicity, customer focus with empowered people, and leadership that inspires teams to embrace change.

• How BMW Bank brought its first AI agent into production—and what it took to get there.
• Where Generative AI adds value—and where rules or traditional machine learning work better
• Practical lessons on ownership, experimentation and governance for scaling AI in a regulated business

Participants work together in this collaborative session to separate genuine clinical value from AI hype, exploring where AI can meaningfully improve trial delivery and where human expertise remains essential

• 5-minute problem statement introducing a sponsor considering AI across multiple areas of clinical trial delivery
• 20-minute whiteboard exercise mapping where AI can add the most value across trial design, recruitment, operations, data and decision making
• 5-minute table presentations comparing each group’s learnings and approaches from the session 

Facilitator: Megan L. Dunham, Director, R&D AI Governance & Portfolio Strategy, Jazz Pharmaceuticals 

Co-Facilitator: Available for event sponsor

• Mastering Rapid Import/Export Adaptation
• Proactive Delays & Cost Management
• Digital Solutions for trade resiliency

• Why recruitment forecasts and feasibility assessments across the DACH region continue to miss targets despite strong research infrastructure and healthcare systems
• How increasing study competition, protocol complexity, and limited patient availability are placing growing pressure on sites
• The operational challenges impacting recruitment and patient access across the region
• How sponsors, CROs, and sites can work together to create more realistic feasibility strategies and more sustainable approaches to patient recruitment and site engagement

Moderator: Karen Cheng, Patient Advocate, The Myositis Association (TMA)